| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Rigshospitaler, University of Copenhagen [L. C.]; Department of Pathology, Frederiksberg and Glostrup County Hospital, Copenhagen [M. N.]; Department of Pathology, University Hospital of Odense, Odense [J. A.]; and Department of Clinical Microbiology and Immunology, Hvidovre Hospital, University of Copenhagen [I. C.]; Denmark
The peripheral stromal fibronectin (FN) staining patterns of invasive breast carcinomas (IBC) from 77 women were compared to the aggressivity of the tumors, which in each case had been determined through a complete clinical follow-up and autopsy investigation. Polyclonal, monospecific rabbit antibody to human FN was applied on formalin-fixed, paraffin-embedded tissue sections using the peroxidase-antiperoxidase staining technique. An FN-positive staining reaction was defined as a constant, diffuse, or pericellular demarcation of FN-positive fibers surrounding tumor cells at the invasive border. In lack of such a staining pattern, FN-negative staining was recorded. The FN-positive staining reaction was significantly associated with a low metastatic potential and appeared in a multivarians analysis to be an excellent prognostic factor, which surpassed other known parameters, such as clinical stage, histological type or grade, and lymph node status. 27 out of 31 women, who died without evidence of metastatic spread, had FN-positive IBC (87%) in contrast to women with metastatic disease, where only 15 out of 46 had FN-positive tumors (33%). An extensive histopathological examination of the contralateral breast revealed in this latter group a high rate of second primaries (22/46), which might have been responsible for the metastatic spread. If these women with bilateral IBC were excluded, only three metastasizing tumors with a FN-positive staining pattern remained, suggesting that the prognostic value of the FN-staining pattern along the invasive border of IBC might be even higher than anticipated from this study.
1 Supported by grants from the Educational Research Council of Greenland, The Faroe Islands and Greater Copenhagen, Denmark, the Danish Medical Research Council, Mrs. Astrid Thaysens Foundation, and the Danish Foundation for the Advancement of Medical Science.
2 To whom reprint requests should be addressed, at the Department of Pathology, Rigshospitalet, Frederik den V's vej 11, 2100 Copenhagen Ø., Denmark.
Received 1/11/88. Revised 6/14/88. Accepted 8/ 2/88.
This article has been cited by other articles:
![]() |
D. S. Rosman, S. Phukan, C.-C. Huang, and B. Pasche TGFBR1*6A Enhances the Migration and Invasion of MCF-7 Breast Cancer Cells through RhoA Activation Cancer Res., March 1, 2008; 68(5): 1319 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sánchez-Carbayo, M. Urrutia, J. M. G. de Buitrago, and J. A. Navajo Evaluation of Two New Urinary Tumor Markers: Bladder Tumor Fibronectin and Cytokeratin 18 for the Diagnosis of Bladder Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3585 - 3594. [Abstract] [Full Text] |
||||
![]() |
C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1 J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |